Lv51
815 积分 2020-12-17 加入
Endophilin A2 improves endothelial dysfunction by counteracting eNOS proteasomal degradation
4小时前
待确认
Current and emerging therapeutic landscape for metabolic dysfunction-associated steatohepatitis
14天前
已完结
Metabolic Dysfunction–Associated Steatotic Liver Disease in Adults
14天前
已完结
Apoptosis signal-regulating kinase 1 (ASK1) inhibition reduces endothelial cytokine production without improving permeability after toll-like receptor 4 (TLR4) challenge
1个月前
已完结
Cardiac α4β2 nicotinic receptors as a therapeutic target for fatal ventricular arrhythmias
2个月前
已完结
Acute respiratory distress syndrome
3个月前
已完结
The immunology of sepsis: translating new insights into clinical practice
4个月前
已完结
Safety and Efficacy of Efruxifermin in Combination With a GLP-1 Receptor Agonist in Patients With NASH/MASH and Type 2 Diabetes in a Randomized Phase 2 Study
4个月前
已完结
A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis
4个月前
已完结
Safety and efficacy of once-weekly efruxifermin versus placebo in non-alcoholic steatohepatitis (HARMONY): a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial
4个月前
已完结
皖公网安备34019202002308
